Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Scientific Reports|July 13, 2017
The energy disruptor metformin targets mitochondrial integrity via modification of calcium flux in cancer cellsCamille Loubiere, Stephan Clavel, Jerome Gilleron, et al.
Cancer Research|January 15, 2017
Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell CarcinomasMaeva Dufies, Sandy Giuliano, Damien Ambrosetti, et al.
Scientific Reports|November 1, 2022
Positive surgical margin's impact on short-term oncological prognosis after robot-assisted partial nephrectomy (MARGINS study: UroCCR no 96)Arnoult Morrone, Imad Bentellis, Jean-Christophe Bernhard, et al.
Theranostics|May 4, 2018
Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinomaMaeva Dufies, Marie Nollet, Damien Ambrosetti, et al.
British Journal of Cancer|August 30, 2017
CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomasMaeva Dufies, Sandy Giuliano, Julien Viotti, et al.
Theranostics|March 21, 2020
Identification of a new aggressive axis driven by ciliogenesis and absence of VDAC1-ΔC in clear cell Renal Cell Carcinoma patientsLucilla Fabbri, Maeva Dufies, Sandra Lacas-Gervais, et al.
Communications Biology|February 6, 2021
Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinomaMaeva Dufies, Annelies Verbiest, Lindsay S Cooley, et al.
Nature Communications|March 14, 2026
Hypusination of the translation factor eIF5A regulates mitochondrial tRNA processing to promote prostate cancer aggressivenessMichel Kahi, Abigail Mazzu, Ludovic Batistic, et al.
BJU International|January 17, 2023
Machine-learning approach for prediction of pT3a upstaging and outcomes of localized renal cell carcinoma (UroCCR-15)Astrid Boulenger de Hauteclocque, Loïc Ferrer, Damien Ambrosetti, et al.
Cell Metabolism|March 5, 2019
GAPDH Expression Predicts the Response to R-CHOP, the Tumor Metabolic Status, and the Response of DLBCL Patients to Metabolic InhibitorsJohanna Chiche, Julie Reverso-Meinietti, Annabelle Mouchotte, et al.
Pageof 9